Yumanity Therapeutics

$17.52
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.08 (-0.45%) Today
$0.00 (0.00%) As of 8:00 PM UTC after-hours

Why Robinhood?

You can buy or sell YMTX and other stocks, options, and ETFs commission-free!

About YMTX

Yumanity Therapeutics, Inc. Common Stock, also called Yumanity Therapeutics, is a clinical stage biopharmaceuticals company.

CEO
Richard Peters
Employees
44
Headquarters
Boston, Massachusetts
Founded
2014
Market Cap
174.44M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
43.44K
High Today
$18.02
Low Today
$17.33
Open Price
$17.33
Volume
23.28K
52 Week High
$23.47
52 Week Low
$15.25

YMTX Earnings

-$0.86
-$0.57
-$0.29
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 13, Pre-Market

You May Also Like

CLII
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure